Skip to main content
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977;70(Suppl 2):2–6.

The pharmacology and subacute toxicology of dopamine.

J F Zaroslinski, L H Possley, R A Schwartz, R N Morris, F A Carone, R K Browne
PMCID: PMC1543337  PMID: 264199

Abstract

Preclinical studies with dopamine showed a unique spectrum of biological activities which suggested that it might be of therapeutic use in the clinical syndromes of shock and low cardiac output. Most prominent among these were its effects on cardiac output, renal perfusion, and vital organ flow. The unique effect on renal function and the subsequent studies by Goldberg and his colleagues led to the recognition of a previously unknown catecholamine receptor site, the 'dopaminergic receptor'. Studies on the toxicology of dopamine in our laboratories suggested that dopamine could be safely used in the clinic.

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman E. L., Harrison D. C. Myocardial hypertrophy resulting from low dosage isoproterenol administration in rats. Proc Soc Exp Biol Med. 1971 Jan;136(1):268–270. doi: 10.3181/00379727-136-35243. [DOI] [PubMed] [Google Scholar]
  2. EBLE J. N. A PROPOSED MECHANISM FOR THE DEPRESSOR EFFECT OF DOPAMINE IN THE ANESTHETIZED DOG. J Pharmacol Exp Ther. 1964 Jul;145:64–70. [PubMed] [Google Scholar]
  3. Endoh M. Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo. Br J Pharmacol. 1975 Dec;55(4):475–486. doi: 10.1111/j.1476-5381.1975.tb07422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FARNSWORTH W. E., LAWRENCE M. H. REGULATION OF PROSTATE SECRETION IN THE RAT. Proc Soc Exp Biol Med. 1965 Jun;119:373–376. doi: 10.3181/00379727-119-30185. [DOI] [PubMed] [Google Scholar]
  5. Farmer J. B. Indirect sympathomimetic actions of dopamine. J Pharm Pharmacol. 1966 Apr;18(4):261–262. doi: 10.1111/j.2042-7158.1966.tb07866.x. [DOI] [PubMed] [Google Scholar]
  6. Goldberg L. I., Talley R. C., McNay J. L. The potential role of dopamine in the treatment of shock. Prog Cardiovasc Dis. 1969 Jul;12(1):40–51. doi: 10.1016/0033-0620(69)90034-6. [DOI] [PubMed] [Google Scholar]
  7. MacCannell K. L., McNay J. L., Meyer M. B., Goldberg L. I. Dopamine in the treatment of hypotension and shock. N Engl J Med. 1966 Dec 22;275(25):1389–1398. doi: 10.1056/NEJM196612222752501. [DOI] [PubMed] [Google Scholar]
  8. McNay J. L., Goldberg L. I. Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther. 1966 Jan;151(1):23–31. [PubMed] [Google Scholar]
  9. Tsai T. H., Langer S. Z., Trendelenburg U. Effects of dopamine and alpha-methyl-dopamine on smooth muscle and on the cardiac pacemaker. J Pharmacol Exp Ther. 1967 May;156(2):310–324. [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES